Your browser doesn't support javascript.
loading
Mechanism of Blood-activating and Toxin-removing Method in Treatment of Coronary Heart Disease and Cognitive Dysfunction Based on Treating Different Diseases with Same Method / 中国实验方剂学杂志
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 185-191, 2022.
Article in Chinese | WPRIM | ID: wpr-943100
ABSTRACT
As China is about to enter an era of deep aging, the coexistence of multiple diseases is gradually increasing. Coronary heart disease (CHD) and cognitive dysfunction also show increasing incidence year by year. The two diseases affect and cause each other, becoming the major chronic diseases harmful to the health of the elderly. It is of great clinical significance to explore the methods integrating traditional Chinese and western medicine for the prevention and treatment of the two diseases. The relationship between CHD and cognitive dysfunction in traditional Chinese medicine (TCM) was first recorded in Huangdi’s Internal Classic (Huang Di Nei Jing). As the understanding of CHD and cognitive dysfunction is deepening, the influences of stasis and toxin on both diseases have attracted increasing attention. According to the theories of TCM, CHD and cognitive dysfunction have common points in the etiology and pathogenesis. Therefore, the theory of treating different diseases with same method provides a theoretical basis for the clinical treatment of different diseases with the same pathogenesis. Moreover, this theory conforms to the principle of integrated and individualized prevention and treatment of multi-disease coexistence in modern medicine. This paper systematically proposed that the coexistence of stasis and toxin is a major pathogenesis of CHD and cognitive dysfunction. We then explored the possible mechanisms of the blood-activating and toxin-removing method in the treatment of CHD and cognitive dysfunction based on the theory of treating different diseases with same method. The mechanisms include the regulation of ceramide metabolism, activation of silent mating-type information regulation 2 homolog 1 (SIRT1), inhibition of pyroptosisregulation of mitogen-activated protein kinase/nuclear factor-κB (MAPK/NF-κB) signaling pathway, inhibition of mitochondrial division, and regulation of DNA methylation. We hope this paper will provide an idea for the future research on the prevention and treatment of CHD and cognitive dysfunction with TCM.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Experimental Traditional Medical Formulae Year: 2022 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Experimental Traditional Medical Formulae Year: 2022 Type: Article